Lin Ni
Private Equity Investor at 6 Dimensions Capital
Profile
Lin Ni is a professional with experience in the biopharmaceutical industry.
Currently, she is a Managing Director at 6 Dimensions Capital.
Previously, she worked as a Managing Director at Frontline Bioventures.
She also held the position of Director at Shanghai Ark Biopharmaceutical Co., Ltd.
for a brief period in 2021.
In addition, she served as a Non-Executive Director at Genor Biopharma Holdings Ltd.
from 2021 to 2022.
Dr. Ni earned a doctorate degree from Osaka University in 2009.
Lin Ni active positions
| Companies | Position | Start |
|---|---|---|
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Private Equity Investor | 17/05/2017 |
Former positions of Lin Ni
| Companies | Position | End |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Director/Board Member | 28/07/2022 |
| Frontline Bioventures | Director/Board Member | 17/05/2017 |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Director/Board Member | - |
Training of Lin Ni
| Osaka University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
| Frontline Bioventures | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Finance |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Lin Ni
